544 related articles for article (PubMed ID: 9376074)
1. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of T cell receptor ligation of TCR gamma delta thymocyte development in fetal thymic organ culture.
Tatsumi Y; Deluca D; Cron RQ; Bluestone JA
Thymus; 1994-1995; 23(3-4):131-53. PubMed ID: 8525502
[TBL] [Abstract][Full Text] [Related]
3. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
4. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
5. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
6. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
7. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
8. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
[TBL] [Abstract][Full Text] [Related]
9. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
10. Ia-positive nonlymphoid cells and T cell development in murine fetal thymus organ cultures: monoclonal anti-Ia antibodies inhibit the development of T cells.
DeLuca D
J Immunol; 1986 Jan; 136(2):430-9. PubMed ID: 2934471
[TBL] [Abstract][Full Text] [Related]
11. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
12. Development of autoreactive diabetogenic T cells in the thymus of NOD mice.
Kwon H; Jun HS; Yang Y; Mora C; Mariathasan S; Ohashi PS; Flavell RA; Yoon JW
J Autoimmun; 2005 Feb; 24(1):11-23. PubMed ID: 15725572
[TBL] [Abstract][Full Text] [Related]
13. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
14. L11, a unique anti-CD43 monoclonal antibody, inhibits the adoptive transfer of diabetes and pancreatic islet, salivary gland, and lacrimal gland inflammation in NOD/scid mice.
Mikulowska A; Johnson GG; Berberian JM; Butcher EC; McEvoy LM; Michie SA
Cell Immunol; 1999 May; 194(1):112-7. PubMed ID: 10357887
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 infectivity of human T cells in a human/murine chimeric fetal thymic organ culture system.
Greiner DL; Shultz LD; Deluca D; Leif JH; Christianson SW; Hesselton RM
In Vivo; 1996; 10(1):33-7. PubMed ID: 8726809
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha mediated modulation of T cell development and exacerbation of in vitro T1DM in fetal thymus organ culture.
Middlebrook AJ; Lebsack T; DeLuca D
J Autoimmun; 2007; 29(2-3):134-45. PubMed ID: 17716860
[TBL] [Abstract][Full Text] [Related]
18. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
Jaakkola I; Jalkanen S; Hänninen A
Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
[TBL] [Abstract][Full Text] [Related]
19. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
20. Use of a microgravity organ culture dish system to demonstrate the signal dampening effects of modeled microgravity during T cell development.
Woods CC; Banks KE; Lebsack TW; White TC; Anderson GA; Maccallum T; Gruener R; DeLuca D
Dev Comp Immunol; 2005; 29(6):565-82. PubMed ID: 15752552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
